Latest News and Press Releases
Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting
December 08, 2024 13:45 ET
|
Beam Therapeutics
NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust Levels of Hemoglobin F mAb Dosing...
רוזן, יועץ השקעות מוביל, מעודד את משקיעי Unisys Corporation לברר לגבי חקירת תביעה ייצוגית בניירות ערך – UIS
December 08, 2024 13:39 ET
|
The Rosen Law Firm PA
ניו יורק, Dec. 08, 2024 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין Rosen Law Firm, משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מודיע על חקירה של תביעות ניירות ערך פוטנציאליות בשם בעלי המניות...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unisys Corporation Investors to Inquire About Securities Class Action Investigation – UIS
December 08, 2024 13:39 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Unisys...
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
December 08, 2024 12:40 ET
|
Agios Pharmaceuticals, Inc.
– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia – – ENERGIZE-T is First Phase 3 Study to Demonstrate...
TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma
December 08, 2024 12:35 ET
|
Janssen Cilag International NV
100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD negativity in MajesTEC-5 as induction therapy and MajesTEC-4 as maintenance therapy1,2 BEERSE, BELGIUM, Dec. ...
Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML
December 08, 2024 12:30 ET
|
Novartis Pharma AG
Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs (74.1% vs. 52%) and vs. imatinib alone (76.2% vs. 47.1%), meeting both ASC4FIRST 96-week key...
Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma
December 08, 2024 12:30 ET
|
F. Hoffmann-La Roche Ltd
Exploratory long-term follow-up analysis of the phase III POLARIX study indicated a positive trend in overall survival in favour of Polivy in combination with R-CHP for people with first-line diffuse...
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
December 08, 2024 12:30 ET
|
C4 Therapeutics, Inc.
In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate (ORR) and 45 Percent Clinical Benefit Rate (CBR);...
業界領先的律師事務所 ROSEN 鼓勵 Symbotic Inc. 投資者在該公司首次提出對 SYM 證券集體訴訟的重要截止日期前聘請律師
December 08, 2024 12:11 ET
|
The Rosen Law Firm PA
紐約, Dec. 09, 2024 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律師事務所 Rosen Law Firm 宣佈代表曾於 2024 年 2 月 8 日至 2024 年 11 月 26 日期間(包括首尾兩日,簡稱「集體訴訟期」)購買 Symbotic Inc. (NASDAQ: SYM) 證券的人士提出集體訴訟。 集體訴訟經已提出。...
ROSEN, A LEADING LAW FIRM, Encourages Symbotic Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SYM
December 08, 2024 12:11 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Symbotic...
- December 08, 2024 02:32 ET EliteSignals Unveils Revolutionary Forex Trading Bot: EliteX
- December 07, 2024 17:39 ET Caribbean Airlines Brings the Region Closer with New Service to Guadeloupe